Home/Filings/4/0001401017-26-000002
4//SEC Filing

Schaeffer Orlov S Nicole 4

Accession 0001401017-26-000002

CIK 0001104506other

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 4:03 PM ET

Size

20.5 KB

Accession

0001401017-26-000002

Insider Transaction Report

Form 4
Period: 2026-01-02
Schaeffer Orlov S Nicole
Chief People Strategy Officer
Transactions
  • Award

    Common Stock

    2026-01-02+5,29341,754 total
  • Exercise/Conversion

    Common Stock

    2026-01-02$13.91/sh+87,290$1,214,204129,044 total
  • Sale

    Common Stock

    2026-01-02$174.28/sh31,030$5,407,90898,014 total
  • Sale

    Common Stock

    2026-01-02$175.17/sh34,103$5,973,82363,911 total
  • Sale

    Common Stock

    2026-01-02$176.08/sh12,832$2,259,45951,079 total
  • Sale

    Common Stock

    2026-01-02$177.17/sh9,125$1,616,67641,954 total
  • Sale

    Common Stock

    2026-01-02$177.78/sh200$35,55641,754 total
  • Award

    Stock Option (right to buy)

    2026-01-02+27,60027,600 total
    Exercise: $177.12Exp: 2036-01-02Common Stock (27,600 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2026-01-0287,2900 total
    Exercise: $13.91Exp: 2029-01-03Common Stock (87,290 underlying)
Footnotes (10)
  • [F1]Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested.
  • [F10]The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.
  • [F2]Each RSU was granted on January 2, 2026 for no consideration.
  • [F3]This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 29, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
  • [F4]This is the weighted average sales price representing 31,030 shares sold at prices ranging from $173.67 to $174.66 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  • [F5]This is the weighted average sales price representing 34,103 shares sold at prices ranging from $174.67 to $175.65 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  • [F6]This is the weighted average sales price representing 12,832 shares sold at prices ranging from $175.67 to $176.62 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  • [F7]This is the weighted average sales price representing 9,125 shares sold at prices ranging from $176.68 to $177.67 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  • [F8]This is the weighted average sales price representing 200 shares sold at prices ranging from $177.72 to $177.84 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  • [F9]These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter until fully vested.

Issuer

INSMED Inc

CIK 0001104506

Entity typeother

Related Parties

1
  • filerCIK 0001401017

Filing Metadata

Form type
4
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 4:03 PM ET
Size
20.5 KB